Skip to main content

Briefing Document

You are here

Providing antiretroviral therapy for mobile populations

Migrant populations are especially vulnerable to HIV and TB. They are at higher risk of infection, face challenges in accessing care, and have a higher risk of poor adherence, treatment interruption, loss to follow-up and treatment failure. High mobility is inherent to Southern Africa, epicentre of the HIV/TB pandemic, yet health systems in the region are not adapted to ensure continuity of chronic care for migrants.

Knowing these patients will be crossing between South Africa and Zimbabwe two to five times a year, a specific model of care w as developed to ensure continuity of chronic care for these highly mobile populations. This report outlines the elements of this strategy and demonstrates the benefits of these tools and strategies that cater to the needs of highly mobile populations in need of chronic care. We hope this model of care, or an adaptation thereof, will help health systems across the region ensure continuity of chronic care among migrant populations.